RT Journal Article SR Electronic T1 The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.31.20114991 DO 10.1101/2020.05.31.20114991 A1 David Ellinghaus A1 Frauke Degenhardt A1 Luis Bujanda A1 Maria Buti A1 Agustín Albillos A1 Pietro Invernizzi A1 Javier Fernández A1 Daniele Prati A1 Guido Baselli A1 Rosanna Asselta A1 Marit M Grimsrud A1 Chiara Milani A1 Fátima Aziz A1 Jan Kässens A1 Sandra May A1 Mareike Wendorff A1 Lars Wienbrandt A1 Florian Uellendahl-Werth A1 Tenghao Zheng A1 Xiaoli Yi A1 Raúl de Pablo A1 Adolfo Garrido Chercoles A1 Graduate in Chemistry A1 Adriana Palom A1 Alba-Estela Garcia-Fernandez A1 Francisco Rodriguez-Frias A1 Alberto Zanella A1 Alessandra Bandera A1 Alessandro Protti A1 Alessio Aghemo A1 Ana Lleo A1 Andrea Biondi A1 Andrea Caballero-Garralda A1 Andrea Gori A1 Anja Tanck A1 Anna Latiano A1 Anna Ludovica Fracanzani A1 Anna Peschuk A1 Antonio Julià A1 Antonio Pesenti A1 Antonio Voza A1 David Jiménez A1 Beatriz Mateos A1 Beatriz Nafria Jimenez A1 Graduate in Biotechnology A1 Carmen Quereda A1 Claudio Angelini A1 Cristina Cea A1 Aurora Solier A1 David Pestaña A1 Elena Sandoval A1 Elvezia Maria Paraboschi A1 Enrique Navas A1 Ferruccio Ceriotti A1 Filippo Martinelli-Boneschi A1 Flora Peyvandi A1 Francesco Blasi A1 Luis Téllez A1 Albert Blanco-Grau A1 Giacomo Grasselli A1 Giorgio Costantino A1 Giulia Cardamone A1 Giuseppe Foti A1 Serena Aneli A1 Hayato Kurihara A1 Hesham ElAbd A1 Ilaria My A1 Javier Martin A1 Jeanette Erdmann A1 José Ferrusquía-Acosta A1 Koldo Garcia-Etxebarria A1 Laura Izquierdo-Sanchez A1 Graduate in Biochemistry, MS A1 Laura Rachele Bettini A1 Leonardo Terranova A1 Leticia Moreira A1 Luigi Santoro A1 Luigia Scudeller A1 Francisco Mesonero A1 Luisa Roade A1 Marco Schaefer A1 Maria Carrabba A1 Maria del Mar Riveiro Barciela A1 Maria Eloina Figuera Basso A1 Maria Grazia Valsecchi A1 María Hernandez-Tejero A1 Marialbert Acosta-Herrera A1 Mariella D’Angiò A1 Marina Baldini A1 Marina Cazzaniga A1 Martin Schulzky A1 Maurizio Cecconi A1 Michael Wittig A1 Michele Ciccarelli A1 Miguel Rodríguez-Gandía A1 Monica Bocciolone A1 Monica Miozzo A1 Nicole Braun A1 Nilda Martínez A1 Orazio Palmieri A1 Paola Faverio A1 Paoletta Preatoni A1 Paolo Bonfanti A1 Paolo Omodei A1 Paolo Tentorio A1 Pedro Castro A1 Pedro M. Rodrigues A1 Aaron Blandino Ortiz A1 Ricardo Ferrer Roca A1 Roberta Gualtierotti A1 Rosa Nieto A1 Salvatore Badalamenti A1 Sara Marsal A1 Giuseppe Matullo A1 Serena Pelusi A1 Valter Monzani A1 Tanja Wesse A1 Tomas Pumarola A1 Valeria Rimoldi A1 Silvano Bosari A1 Wolfgang Albrecht A1 Wolfgang Peter A1 Manuel Romero Gómez A1 Mauro D’Amato A1 Stefano Duga A1 Jesus M. Banales A1 Johannes R Hov A1 Trine Folseraas A1 Luca Valenti A1 Andre Franke A1 Tom H Karlsen YR 2020 UL http://medrxiv.org/content/early/2020/06/02/2020.05.31.20114991.abstract AB Background Respiratory failure is a key feature of severe Covid-19 and a critical driver of mortality, but for reasons poorly defined affects less than 10% of SARS-CoV-2 infected patients.Methods We included 1,980 patients with Covid-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian and Barcelona) for a genome-wide association analysis. After quality control and exclusion of population outliers, 835 patients and 1,255 population-derived controls from Italy, and 775 patients and 950 controls from Spain were included in the final analysis. In total we analyzed 8,582,968 single-nucleotide polymorphisms (SNPs) and conducted a meta-analysis of both case-control panels.Results We detected cross-replicating associations with rs11385942 at chromosome 3p21.31 and rs657152 at 9q34, which were genome-wide significant (P<5×10−8) in the meta-analysis of both study panels, odds ratio [OR], 1.77; 95% confidence interval [CI], 1.48 to 2.11; P=1.14×10−10 and OR 1.32 (95% CI, 1.20 to 1.47; P=4.95×10−8), respectively. Among six genes at 3p21.31, SLC6A20 encodes a known interaction partner with angiotensin converting enzyme 2 (ACE2). The association signal at 9q34 was located at the ABO blood group locus and a blood-group-specific analysis showed higher risk for A-positive individuals (OR=1.45, 95% CI, 1.20 to 1.75, P=1.48×10−4) and a protective effect for blood group O (OR=0.65, 95% CI, 0.53 to 0.79, P=1.06×10−5).Conclusions We herein report the first robust genetic susceptibility loci for the development of respiratory failure in Covid-19. Identified variants may help guide targeted exploration of severe Covid-19 pathophysiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe IKMB's core facilities received infrastructure support by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI, EXC2167). The project also received support through a philanthropic donation by Stein Erik Hagen and Canica AS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The following ethical approvals of the project were obtained from the relevant ethics committees: Germany: Kiel (reference number D464/20); Italy: Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico (reference number 342_2020 and 334-2020 for cases and controls, respectively), Humanitas Clinical and Research Center, IRCCS (reference number 316/20), San Gerardo Hospital School of Medicine, Monza (the ethics committee of the National Institute of Infectious Diseases Lazzarro Spallanzani reference number 84/2020); Norway: Regional Committee for Medical and Health Research Ethics in South-Eastern Norway (reference number 132550); Spain: Hospital Clinic and IDIBAPS, Barcelona (reference number HCB/2020/0405), Hospital Universitario Vall d'Hebron, Barcelona (reference PR[AG]244/2020), Hospital Universitario Ramon y Cajal, Madrid (reference number 093/20), Donostia University Hospital, San Sebastian (reference number PI2020064).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics will be made available upon request and after signing of appropriate institutional data transfer agreements, after acceptance of the peer-reviewed manuscript.